Vote Scores

Home / Companies / SK bioscience Co., Ltd. / 23 Mar 2026

Meeting · year to 30 June 202625 filers reporting

SK bioscience Co., Ltd.: meeting of 23 Mar 2026

Votes reported on Form N-PX, item by item

25 Form N-PX filers reported votes at the SK bioscience Co., Ltd. meeting of 23 Mar 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

4 nominees; 67.4% of reported votes for; 15 filers withheld from or voted against at least one nominee.

132 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.

50.0% for0.0% against50.0% other0.0% against management24 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

2 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management1 filers100.0% for0.0% against0.0% against management5,754 reported shares
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

31 vote records from 22 filers. 0 of the 22 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management22 filers100.0% for0.0% against0.0% against management449,662 reported shares, counted once per item in this group
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

102 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management24 filers100.0% for0.0% against0.0% against management1,843,554 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

75 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management24 filers89.7% for10.3% against10.3% against management1,604,727 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors
VanguardSplit or no vote
BlackRock and iSharesFor
FidelityFor
DimensionalSplit or no vote
State Street and SPDRFor
American CenturySplit or no vote
Franklin TempletonSplit or no vote
Charles SchwabFor
Nuveen and TIAAFor
Goldman SachsFor
Northern Trust and FlexSharesSplit or no vote
BNY MellonSplit or no vote

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the SK bioscience Co., Ltd. meeting?

25 Form N-PX filers reported votes at the meeting of 23 Mar 2026. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by SK bioscience Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for SK bioscience Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing SK bioscience Co., Ltd. with a meeting date within three days of 23 Mar 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.